Cargando…

Structural and functional properties of the Kunitz-type and C-terminal domains of Amblyomin-X supporting its antitumor activity

Amblyomin-X is a Kunitz-type FXa inhibitor identified through the transcriptome analysis of the salivary gland from Amblyomma sculptum tick. This protein consists of two domains of equivalent size, triggers apoptosis in different tumor cell lines, and promotes regression of tumor growth, and reducti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morais, K. L. P., Ciccone, L., Stura, E., Alvarez-Flores, M. P., Mourier, G., Driessche, M. Vanden, Sciani, J. M., Iqbal, A., Kalil, S. P., Pereira, G. J., Marques-Porto, R., Cunegundes, P., Juliano, L., Servent, D., Chudzinski-Tavassi, A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948614/ https://www.ncbi.nlm.nih.gov/pubmed/36845546 http://dx.doi.org/10.3389/fmolb.2023.1072751

Ejemplares similares

Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity
por: Maria, Durvanei A., et al.
Publicado: (2018)

Dynein Function and Protein Clearance Changes in Tumor Cells Induced by a Kunitz-Type Molecule, Amblyomin-X
por: Pacheco, Mario T. F., et al.
Publicado: (2014)

Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells
por: Schmidt, Mariana Costa Braga, et al.
Publicado: (2018)

A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate
por: Lobba, Aline R. M., et al.
Publicado: (2022)

Amblyomin-X induces ER stress, mitochondrial dysfunction, and caspase activation in human melanoma and pancreatic tumor cell
por: Morais, Katia L. P., et al.
Publicado: (2016)

New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X
por: Pavon, Lorena Favaro, et al.
Publicado: (2019)

Modulation of stress and immune response by Amblyomin-X results in tumor cell death in a horse melanoma model
por: Lichtenstein, Flavio, et al.
Publicado: (2020)

Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model
por: de Souza, Jean Gabriel, et al.
Publicado: (2016)

Copper mediated amyloid-β binding to Transthyretin
por: Ciccone, Lidia, et al.
Publicado: (2018)

Losac and Lopap Recombinant Proteins from Lonomia obliqua Bristles Positively Modulate the Myoblast Proliferation Process
por: Alvarez, Angela María, et al.
Publicado: (2022)

Proteomic informed by transcriptomic for salivary glands components of the camel tick Hyalomma dromedarii
por: Bensaoud, Chaima, et al.
Publicado: (2019)

Kunitz type protease inhibitor from the canine tapeworm as a potential therapeutic for melanoma
por: Ranasinghe, Shiwanthi L., et al.
Publicado: (2019)

Ancestral protein resurrection and engineering opportunities of the mamba aminergic toxins
por: Blanchet, Guillaume, et al.
Publicado: (2017)

Dithiocarbazate ligands and their Ni(II) complexes with potential biological activity: Structural, antitumor and molecular docking study
por: Cavalcante, Cássia de Q. O., et al.
Publicado: (2023)

Editorial: Venom Peptides: A Rich Combinatorial Library for Drug Development
por: Cardoso, Fernanda C., et al.
Publicado: (2022)

Editorial: Venom peptides: A rich combinatorial library for drug development, volume II
por: Servent, Denis, et al.
Publicado: (2023)

Engineering of Three-Finger Fold Toxins Creates Ligands with Original Pharmacological Profiles for Muscarinic and Adrenergic Receptors
por: Fruchart-Gaillard, Carole, et al.
Publicado: (2012)

MODIFICATION OF THE NORTHROP-KUNITZ MICROCATAPHORESIS CELL
por: Abramson, Harold A.
Publicado: (1929)

Characterization and Pharmacological Properties of a Novel Multifunctional Kunitz Inhibitor from Erythrina velutina Seeds
por: Machado, Richele J. A., et al.
Publicado: (2013)

Evaluation of the Spider (Phlogiellus genus) Phlotoxin 1 and Synthetic Variants as Antinociceptive Drug Candidates
por: Gonçalves, Tânia C., et al.
Publicado: (2019)

Cloning and Characterization of Two Potent Kunitz Type Protease Inhibitors from Echinococcus granulosus
por: Ranasinghe, Shiwanthi L., et al.
Publicado: (2015)

A Lipocalin-Derived Peptide Modulating Fibroblasts and Extracellular Matrix Proteins
por: Carrijo-Carvalho, Linda Christian, et al.
Publicado: (2012)

Unexpected Activity of a Novel Kunitz-type Inhibitor: INHIBITION OF CYSTEINE PROTEASES BUT NOT SERINE PROTEASES
por: Smith, David, et al.
Publicado: (2016)

Plant Kunitz Inhibitors and Their Interaction with Proteases: Current and Potential Pharmacological Targets
por: Bonturi, Camila Ramalho, et al.
Publicado: (2022)

Structural and Functional Diversity of Animal Toxins Interacting With GPCRs
por: Van Baelen, Anne-Cécile, et al.
Publicado: (2022)

Lonomia obliqua Venom Induces NF-κB Activation and a Pro-Inflammatory Profile in THP-1-Derived Macrophage
por: Oliveira, Douglas Souza, et al.
Publicado: (2021)

Arabidopsis Kunitz Trypsin Inhibitors in Defense Against Spider Mites
por: Arnaiz, Ana, et al.
Publicado: (2018)

Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study
por: Beeckmans, Sonia, et al.
Publicado: (2021)

Predicting the Specificity- Determining Positions of Receptor Tyrosine Kinase Axl
por: Karakulak, Tülay, et al.
Publicado: (2021)

Functional expression of a novel Kunitz type protease inhibitor from the human blood fluke Schistosoma mansoni
por: Ranasinghe, Shiwanthi L., et al.
Publicado: (2015)

Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer
por: Ranasinghe, Shiwanthi L., et al.
Publicado: (2018)

TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
por: Nai, Yaru, et al.
Publicado: (2021)

Thioredoxin Reductase Inhibitors as Potential Antitumors: Mercury Compounds Efficacy in Glioma Cells
por: Pires, Vanessa, et al.
Publicado: (2022)

Advanced applications of DNA nanostructures dominated by DNA origami in antitumor drug delivery
por: Zhang, Yiming, et al.
Publicado: (2023)

Decoy Plasminogen Receptor Containing a Selective Kunitz-Inhibitory Domain
por: Kumar, Yogesh, et al.
Publicado: (2014)

Biodegradable manganese-doped hydroxyapatite antitumor adjuvant as a promising photo-therapeutic for cancer treatment
por: Park, Sumin, et al.
Publicado: (2022)

Structure of conkunitzin-S1, a neurotoxin and Kunitz-fold disulfide variant from cone snail
por: Dy, Catherine Y., et al.
Publicado: (2006)

An atypical and functionally diverse family of Kunitz-type cysteine/serine proteinase inhibitors secreted by the helminth parasite Fasciola hepatica
por: Smith, David, et al.
Publicado: (2020)

Revisiting antithrombotic therapeutics; sculptin, a novel specific, competitive, reversible, scissile and tight binding inhibitor of thrombin
por: Iqbal, Asif, et al.
Publicado: (2017)

S. mansoni SmKI-1 Kunitz-domain: Leucine point mutation at P1 site generates enhanced neutrophil elastase inhibitory activity
por: Mambelli, Fábio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_phtastc683urb4e1pepre7o8mq